
TRAK is a company that has developed artificial intelligence-powered digital rehabilitation software for musculoskeletal injuries. Its technology recognises more than 40 joint movements of the patient using their smartphone camera to accompany them in their treatment based on therapeutic exercise with real-time feedback. With TRAK's system, healthcare professionals or centres are able to offer up to four times more treatments with a hybrid method that combines face-to-face and digital sessions. Currently, the company works with leading healthcare entities in Spain such as Mapfre, Sanitas, Quiron Salud and Mutua Universal, consolidating its position as a leader in the national market. The company has started its international career with presence in large entities such as Keralty or Teladoc in LATAM and Europe.

TRAK is a company that has developed artificial intelligence-powered digital rehabilitation software for musculoskeletal injuries. Its technology recognises more than 40 joint movements of the patient using their smartphone camera to accompany them in their treatment based on therapeutic exercise with real-time feedback. With TRAK's system, healthcare professionals or centres are able to offer up to four times more treatments with a hybrid method that combines face-to-face and digital sessions. Currently, the company works with leading healthcare entities in Spain such as Mapfre, Sanitas, Quiron Salud and Mutua Universal, consolidating its position as a leader in the national market. The company has started its international career with presence in large entities such as Keralty or Teladoc in LATAM and Europe.
What they do: AI-powered digital physiotherapy and telerehabilitation platform
Location: Valencia, Spain
Team size: Approximately 40 employees
Reported impact: ~70–75% adherence; patient satisfaction ~9.2–9.25/10
Recent funding: Seed round; total funding reported ~$1.59M (USD); last funding date 2024-02-01
| Company |
|---|
Digital physiotherapy / telerehabilitation; remote rehabilitation and adherence monitoring
Healthcare; Digital Health / MedTech
1590000.00
Seed-stage funding reported; investor mentions include Decelera and Basque Fondo in public records, but lead investor not explicitly confirmed in the evidence provided.
“Basque Fondo recorded as an investor; Crunchbase lists multiple seed investors including Decelera and named individuals.”